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Abstract 
 
Objective: To improve survival rates during cardiopulmonary resuscitation (CPR), some patients 
are put on extracorporeal life support (ECLS) during active resuscitation (ECPR). Our objective 
was to assess the clinical outcomes after pediatric ECPR in Switzerland and to determine pre-
ECPR prognostic factors for mortality. 
Design: Retrospective analysis 
Setting: Three pediatric intensive care units in Switzerland that use ECPR 
Patients: All patients (<16 years old) undergoing ECPR from 2008 to 2016 
Interventions: None  
Measurements and Main Results: Data before ECLS initiation and clinical outcomes were 
collected. An ECPR score was designed to predict mortality, based on variables significantly 
different between survivors and non-survivors. 55 patients were included, with a median age of 
13.5 months. Eighty percent were cardiac patients. The mortality rate was 75%. Mortality was 
significantly associated with CPR duration (p=0.02), last lactate (p=0.05) and last pH (p=0.01) 
before ECLS initiation. Based on these three variables, an ECPR score was designed as follows: 
CPR duration (in minutes): 1 point if <40; 2 points if ≥40; 3 points if ≥60; 6 points if ≥105. 
Lactate (in mmol/L): 1 point if <8; 2 points if ≥8; 3 points if ≥14; 6 points if ≥18. pH: 1 point if 
>7.00; 2 points if ≤7.00; 3 points if ≤6.85; 6 points if ≤6.60. The area under the receiver-
operating characteristic curve was 0.74. The positive predictive value of a score ≥ 9 was 94%. 
Conclusions: In our population, a score based on three variables easily available prior to ECLS 
initiation had good discrimination and could appropriately predict mortality. This score now 
needs validation in a larger population. 
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Prognostic Evaluation of Mortality after Pediatric Resuscitation Assisted by 
Extracorporeal Life Support 
 
Introduction 
 Extracorporeal cardiopulmonary resuscitation (ECPR) allows for adequate tissue 
perfusion in certain situations of refractory cardiac arrest, when prolonged conventional 
cardiopulmonary resuscitation (CCPR) failed to restore spontaneous circulation. The first reports 
of pediatric ECPR date back to the 1980s. (1) A large pediatric ECPR study including 3756 
patients showed greater survival and better neurological outcome with ECPR compared to CCPR 
(40% versus 27%, and 27% versus 18%, respectively). (2) The Extracorporeal Life Support 
Organization (ELSO) Registry reports an increased number of ECPR patients by 67% from 2009 
to 2015. (3) The only international guidelines currently in use were published by the 
International Liaison Committee on Resuscitation (ILCOR) in 2015. It suggests considering 
ECPR for cardiac diagnoses who have in-hospital cardiac arrest. (4) Identifying the best 
candidates for pediatric ECPR is mandatory. Indeed, despite its wide acceptance and use, ECPR 
is an invasive mechanical support that is associated with an important morbidity and mortality 
due to ECMO-related complications. Moreover, depending on the patient’s neurological 
prognosis, its use might be futile, and even harmful. Lastly, this complex technique requires 
substantial financial and human resources. 
 Aiming to improve patient selection, some authors identified prognostic factors for 
mortality. Joffe et al. reviewed factors predicting mortality in 17 studies including 762 pediatric 
patients with ECPR between 2000 and 2011. (5) The most significant factors were a non-cardiac 
disease leading to cardiac arrest, an acute kidney failure during extracorporeal life support 
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(ECLS), neurological complications during ECLS, and a very low pH during ECLS. 
Unfortunately, these factors are not helpful to decide whether or not ECPR should be initiated, as 
most of these risk factors can only be assessed after ECMO initiation. 
 The aim of our study is to report ECPR clinical outcomes in three Swiss tertiary Pediatric 
Intensive Care Units (PICUs), to identify factors associated with mortality and to establish a 
prognostic score for mortality, using variables that are available prior to ECLS initiation. 
 
Materials and Methods 
 This report describes a retrospective study performed in three tertiary PICUs in Geneva, 
Lausanne, and Zurich, Switzerland, from January 2008 to December 2016. We included all 
consecutive children (<16 years old) at these three institutions who underwent ECPR; no 
exclusion criteria were utilized in this study, and each qualifying patient was included. ECPR is 
defined, according to ELSO, as ECMO cannulation during CPR with ongoing chest 
compressions.  
 This study was approved by the ethics review board “Commission Cantonale d’Ethique 
de la Recherche”, which waived the need for individual consent. 
 
Outcomes 
 The primary outcome was in-hospital mortality after ECLS initiation. The secondary 
outcome was neurological status of hospital survivors at discharge, as assessed by the Pediatric 
Cerebral Performance Category (PCPC) score. (6) The PCPC score evaluates cognitive 
impairment. It has six categories: 1) Normal outcome; 2) Mild disability (regular school, but 
grades perhaps not age-appropriate); 3) Moderate disability (age-appropriate independent 
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activities of daily life but special education classroom and/or learning deficit present); 4) Severe 
disability (dependent on others for daily support because of impaired brain function); 5) Coma or 
vegetative state (without interaction with the environment); and 6) Brain death. This assessment 
was systematically performed by a trained physician for every patient who had a history of 
cardiac arrest. We recorded demographic data, diagnosis at PICU admission, presence of 
comorbidities, suspected etiology of circulatory arrest, last laboratory tests before ECLS 
initiation, length of CPR until ECLS initiation, central or peripheral ECLS cannula insertion site, 
ECLS duration, length of PICU stay, and, when applicable time and cause of death. Co-
morbidities were defined as any condition associated with organ dysfunction that required 
support in a critical care setting. ECLS initiation is defined as the time between circulatory arrest 
and oxygenated blood flow returned to the patient through the ECLS circuit. 
 For patients with two ECPR events, only the second run was used to evaluate the 
mortality outcome. 
 
ECLS programs 
 Geneva’s PICU has an average of 150 postoperative cardiac patients per year over the 
last 9 years and an average of 8 ECLS runs per year over the five last years. Its ECLS program 
was initiated in 1996. Lausanne’s PICU has an average of 150 postoperative cardiac patients per 
year as well. Their first ECLS occurred in 2011, but the ECLS program formally began in 2015. 
Zurich’s PICU has an average of 240 postoperative cardiac surgery patients per year. Zurich’s 
ECLS program was initiated in 2004 with an average of 9 ECLS runs per year over the nine-year 
study period. An average of 15 ECLS runs per year were performed in the last 5 years.  
In all three centers, ECLS cannulation is always performed by cardiac surgeons in 
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collaboration with specialized perfusion technicians, none of which are in-house during nights 
and weekends. There is no formal ECPR recommendation in place. Hypothermia is not used 
after cardiac arrest, but hyperthermia is actively avoided in these patients. 
 
Statistical analysis 
 Descriptive statistics are reported as mean ± standard deviation (SD), median 
(interquartile range, IQR), or proportions with their 95% confidence intervals (CIs). Due to the 
small sample size non-parametric tests were used to evaluate the association between pre-ECLS 
initiation variables and survival status: Mann-Whitney U test for continuous variables and 
Fisher’s Exact test for dichotomous variables. All tests were two-sided, with an alpha level of 
0.05. The power to detect an AUC of 0.75 with an alpha of 0.05 and an allocation ratio of 2.92:1 
(41 non-survivors, 14 survivors) was 90%. 
 
Design and testing of the score 
 We used the following strategy to design the ECPR score to predict mortality. All 
variables that were significantly associated with mortality were used for the score after 
demonstrating the absence of co-linearity. Three cutoffs, delimiting four categories, were 
identified for each variable in the score based on the 25th, 50th and 75th percentile of the values in 
the non-surviving group. The coefficients for each category were based on the individual risk 
ratios of mortality for that category compared to the next. The final coefficients were based on 
the average risk for all three variables and were within the 95% CI of the risk ratio, in order to 
have a homogenous and simple score. Of note, it was not possible to use a logistic regression 
model to design the score due to the small sample size. 
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 The performance of the score was evaluated as follows: Discrimination, which refers to 
the ability of the score to separate non-survivors from survivors across the whole group, (7) was 
evaluated using the area under the receiver-operating characteristic curve with its 95% CI. The 
sensitivity analysis was performed with a Youden’s J statistic calculation. 
  Calibration was assessed by directly comparing the observed and customized predicted 
mortality across subcategories of risk. We employed the Hosmer–Lemeshow goodness-of-fit 
test, where a p value >0.05 indicates acceptable calibration. (8) 
 All statistical analyses were performed with SPSS version 24 for Mac (IBM, Armonk, 
NY, USA). 
 
Results 
Demographic data 
 Over 9 years, 55 patients were treated with 56 ECPR (one patient required two ECPRs 
and died after the second run). Sixty-four percent (35/55) were male. The median weight was 
7.55 kg (IQR 4.25-20.0) and the median age 13.5 months (IQR 1-69). As showed in Figure 1, 
80% (45/55) of the patients had cardiac conditions leading to circulatory arrest. The 34 
congenital heart defect were physiologically univentricular heart (n=8), conotruncal heart defect 
(n=8), transposition of the great arteries (n=7), heterotaxy anomaly (n=4), valvulopathy (n=4), 
and ventricular septal defect (n=3). The median number of circulatory arrests prior to ECLS 
initiation was 1 (IQR 1-2). The median length of CPR prior to ECLS initiation was 60 minutes 
(IQR 40-90).  
 
ECLS run and outcome 
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 The median length of ECLS was 105 hours (IQR 52-162). Cannulation was central for 
2/3 patients in Lausanne, 12/22 in Geneva, and 26/27 in Zurich (p=0.002). Central cannulation 
was performed in 71% (10/14) of the survivors versus 79% (32/41) of the non-survivors 
(p=0.71). 
 The overall hospital mortality rate was 75% (41/55). Sixty-four percent (26/41) died of 
multiple organ failure, 34% (14/41) of brain death or devastating hypoxic ischemic 
encephalopathy, and 2% (1/41) of hemorrhagic shock. Seventy-three percent (30/41) of the 
patients died while on ECLS, as a consequence of multiple organ failure (n=16), brain death 
(n=7), severe anoxic-ischemic encephalopathy (n=4), refractory heart failure (n=1), refractory 
hemorrhagic shock (n=1), and sepsis (n=1).  
Twenty-seven percent (11/41) of the patients died after ECLS decannulation after a median of 12 
days (IQR 1-30). Fifty-five percent (6/11) died of multiple organ failure and 45% (4/11) died 
after redirection of care, due to severe anoxic-ischemic encephalopathy. 
 Fourteen patients (25%) survived ECPR and were discharged alive. Seven patients (50% 
of survivors, 13% of all patients) had no neurological deficit, as defined by a PCPC score of 1. 
Two patients (14% of survivors) had mild disabilities (PCPC score of 2), whereas four patients 
(28% of survivors) had moderate disabilities (PCPC score of 3), and one patient (7% of 
survivors) had severe disabilities (PCPC score of 4).  
There was no significant change in the mortality rate from 2008 to 2016. (p=0.28). 
 
Risk factor for mortality  
 The variables measured prior to ECLS initiation are available in Table 1. 
 Mortality was significantly associated with length of CPR before ECLS initiation, last 
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lactate, and last pH before ECLS initiation (p=0.02, p=0.05, and p=0.01, respectively). There 
was a poor correlation between pH and lactates (Pearson R2 = 0.09). The presence of 
comorbidities and underlying cardiac conditions were not associated with worse outcomes after 
ECPR (p=0.9 and p=0.71 respectively). 
 
Score to predict mortality after ECPR 
 Based on these three variables, we designed an ECPR score. The thresholds for each 
variable were based on the quartiles in the non-survivors. The coefficient of each category was 
based on the relative risk of mortality compared to baseline (Table 2). The final score is 
presented in Table 3. The score ranges from 3 to 18 points. 
 Each incremental point increased the risk of mortality by 39% (p=0.01). Using a cut-off 
of ≥ 9, the sensitivity, specificity, and positive predictive value were 41% (95%CI 26-58), 93% 
(95%CI 66-100), and 94% (95%CI 71-99), respectively (Figure 2).  
 
Discrimination and calibration of the score 
 The area under the receiver-operating characteristic curve was 0.74 (95%CI 0.61-0.87). 
The Hosmer–Lemeshow Chi-square value was 4.33 (p = 0.63). 
 
Discussion 
 In this study, we found a significant association between mortality and length of CPR, 
last lactate, and last pH before ECLS initiation. We used those variables, easily available prior to 
ECLS initiation, to design a score to predict mortality.  
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 The parameters that are used in this score have a sound physiological basis. Serum lactate 
and pH before ECLS initiation reflect the severity of tissue hypoxemia and are an indicator of 
oxygen delivery and hence CPR quality, although they might also reflect renal or liver failure. 
The association between lactate and pH with mortality in our study is in accordance with other 
previous pediatric and adult findings. (5, 9, 10) Thus, in a pediatric series of 695 ECPR, the risk 
of mortality was halved when the pre-ECMO pH was above 7.17. (11) Recently, a large adult 
meta-analysis including 841 ECPR showed that survivors had significantly lower serum lactate 
concentration (-3.53 mmol/L) than non-survivors. (12)  
 We also found a significant association between length of CPR before ECLS initiation 
and mortality. The effect of CPR duration is debated. Some authors have suggested that there 
was no association between CPR duration before ECLS initiation and mortality. (13-16) 
In our series, prolonged CPR duration might be due to a few factors. For example, some out-of-
hospital cardiac arrest cases were put on ECMO and were hence included in the study; the 
absence of in-house ECMO teams during nights and weekends might potentially have prolonged 
CPR time; and some attendings might have beliefs that prolonged CPR time does not always 
lead to unfavorable outcome. For example, we report a patient with grossly intact neurological 
status at the time of discharge despite prolonged CPR duration up to 120 minutes. Other case 
series and case reports have reported ECPR survivors with favorable neurological outcome after 
CPR length up to 220 minutes. (17-19) On the other hand, Matos et al. published a large 
prospective and multicenter study, which included 3419 children with cardiac arrest between 
2000 and 2009. (20) They showed that when CRP lasted between 1 and 15 minutes, survival 
decreased by 2.1% per minute and favorable neurological outcomes decreased by 1.2% per 
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minute. Adjusted probability of survival was 41% for CPR duration of 1 to 15 minutes and 12% 
for more than 35 minutes. A meta-analysis including 288 pediatric patients with ECPR showed 
that mortality was doubled when the duration of CPR was longer than 30 minutes (odd-ratio 2.1). 
(21) The previously cited large adult meta-analysis by Debaty et al revealed that a shorter CPR 
duration before ECLS was significantly associated with survival. (12) Other recent pediatric and 
adult population studies support these data. (9, 22-25) Therefore, it seems biologically plausible 
that increased length of CPR before ECLS initiation is associated with worse clinical outcome, 
especially in conjunction with markers of poor end-organ perfusion indicating insufficient 
oxygen delivery. 
 The score, which was derived from variables available before ECLS initiation, accurately 
predicted mortality after ECLS initiation. The area under the receiver-operating characteristic 
curve of 0.74, considered as good, (8) is comparable to other clinical scores reported in the 
ELSO registry. (26) Using a cutoff of 9, this score has a positive predictive value of 94%. This 
could aid clinicians when making the final decision to initiate ECLS and perhaps avoid futile 
treatment, especially in the centers without a 24/7 in-house ECMO team, resulting in potentially 
long durations of CPR. It needs to be considered that if the benefits do not outweigh the negative 
side effects for a particular treatment/therapy, that it might be in the patient’s best interest to 
withhold that treatment/therapy. (27) Furthermore, in the setting of limited resources and the 
ethical principle of resource equality, the attending physician has the duty to reasonably allocate 
costly and potential futile treatment options. 
 This study is subject to various limitations, mostly inherent to retrospective observational 
series. First, due to small sample size multivariate analyses were not possible. Then, as there is 
no formal ECPR recommendation in place, the decision to escalate level of care to ECMO was 
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left to the attending physician, and there was no control group which benefited from CPR only. 
Additionally, our survival rates were lower than those of the ELSO registry, which could limit 
the generalization of our results. Our results could be explained in part by our ECPR 
organization without in-house cardiac surgery and perfusionist teams during nights and 
weekends. Furthermore, the variables we collected cannot entirely describe the complex pre-
ECMO situation, which might have led to some bias. However, the variables that were collected 
are similar to those reported in other studies. Moreover, as we focused on pre-ECMO variables, 
we did not report ECMO complication, which might have been associated with clinical outcome. 
Afterwards, regarding demographic data, we did not collect whether the patient was admitted 
through the emergency department (out-of-hospital cardiac arrest (OHCA)) or was already 
admitted in the hospital (in-hospital cardiac arrest (IHCA)). This location factor might influence 
our results, although CPR duration reflects OHCA and last pH/lactate before cannulation is a 
surrogate marker for CPR quality. Also, the exact delay between the last blood gas and the 
initiation of ECMO was not recorded. However, the concept of "last gas prior to ECMO 
initiation" is pragmatic and therefore strengthens the generalizability of our results. Furthermore, 
because of the retrospective design, we were not able to assess the CPR quality. Besides, 
although there might have been some changes in technology and management protocols over 
time, this did not influence the outcome in our series. Finally, like most pediatric ECPR studies, 
we were not able to systematically assess both non-focal and long-term neurological outcomes. 
 
Conclusion 
 The identification of appropriate ECPR candidates remains an ongoing challenge for all 
the ECPR centers and implies integration of patient-related factors that can predict mortality. In 
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our population, a score based on three variables, i.e. length of CPR, last pH, and last lactate, 
easily available prior to ECLS initiation, had a good discrimination and could appropriately 
predict mortality. This score now needs to be evaluated in a larger population. 
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Figures 
 
Figure 1. Flow-chart of the population, describing the patients with cardiac diagnoses and those 
with non-cardiac diagnoses. The table below the flowchart describes the outcome between these 
two subgroups. 
 
Figure 2. Boxplot of the extracorporeal life support during active resuscitation (ECPR) score, in 
the patients who survived (light grey) and who died (dark gray); p=0.01. The horizontal dashed 
line represented the cut-off value of 9 points, which had a positive predictive value of 94% 
(95%CI 71-99).  
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Tables 
 
 
Table 1: Variables available prior to extracorporeal life support initiation 
Variables Number of 
patients in which 
it was measured 
Survivors 
n=14 
Non-survivors 
n=41 
p 
Age (years) 55 1.4 (0.4-8) 1.0 (0.1-5.4) 0.47 
Weight (kg) 55 10.0 (5.6-26.9) 7.3 (3.9-19.5) 0.22 
Underlying cardiac condition 55 12 (86%) 31 (76%) 0.71 
Comorbidities 55 4 (29%) 14 (27%) 0.9 
Length of CPR (minutes) 52 45 (18-49) 60 (40-105) 0.02 
Last lactate (mmol/l) 50 11.1 (5.5-14.2) 13.9 (8.1-17.5) 0.05 
Last potassium (meq/l) 51 4.6 (4.1-5.3) 5.2 (4.2-6.8) 0.17 
Last pH 50 7.06 (6.9-7.16) 6.85 (6.58-7.02) 0.01 
Last pCO2 (torr) 50 56 (44-77) 71 (44-105) 0.48 
Last bicarbonate (mmol/l) 50 12.2 (9.6-18.5) 11.4 (5.8-17.7) 0.27 
Absent pupillary reflex 11 1 (7%) 3 (7%) 0.36 
Values are presented as either median and IQR or number and proportion. Laboratory values 
were the last measured prior to ECLS initiation. 
CPR, cardio-pulmonary resuscitation; pCO2, partial pressure of carbon dioxide; ECLS, 
extracorporeal life support. 
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Table 2: Univariate risk ratio and 95%CI of mortality, for the second, third, and fourth 
category in reference to the first category. The average risk for the three variables is presented 
on the last line. 
Variables 1st quartile 2nd quartile 3rd quartile 4th quartile 
Length of CPR (minutes) Ref 1.0 (0.2-4.5) 4.6 (0.7-30.4) 7.1 (0.6-75.1) 
Lactate (mmol/l) Ref 1.4 (0.3-6.4) 1.9 (0.3-10.4) No survivor 
pH Ref 4.1 (0.7-24.0) 3.6 (0.6-21.6) No survivor 
Average risk 1 2.2 3.4 7.1 
CPR, cardiopulmonary resuscitation; Ref, reference. 
The different quartiles are <40, 40-59, 60-104, and ≥ 105 for length of CPR; < 8.0, 8.0-13.9, 
14.0-17.9, and ≥ 18.0 for lactates; and > 7.0, 6.85-7.0, 6.61-6.84, and ≤ 6.60 for pH, 
respectively. 
For example, a patient with a lactate of 14.0 mmol/L (in the third quartile) has a 1.9-fold 
increase in risk of mortality, as compared to a patient with a lactate of 7.0 mmol/L. 
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Table 3: Score to predict mortality after extracorporeal life support during active resuscitation  
Variables 1 point 2 points 3 points 6 points 
Length of CPR (minutes) <40 40 to 59 60 to 104 ≥ 105 
Lactate (mmol/l) < 8.0 8.0 to 13.9 14.0 to 17.9 ≥ 18.0 
pH > 7.00 6.85 to 7.00 6.61 to 6.84 ≤ 6.60 
If a variable was not measured prior to ECLS initiation, it was considered to be normal. 
CPR, cardiopulmonary resuscitation; ECLS, extracorporeal life support. 
 
55 patients
Cardiac diagnoses (n=45) Non-cardiac diagnoses (n=10)
Congenital heart defect (n=34)
Dilated cardiomyopathy (n=6)
Hypertrophic cardiomyopathy (n=1)
Idiopathic pulmonary hypertension (n=1)
Kawasaki disease (n=1)
Intractable arrhythmia (n=1)
Viral myocarditis (n=1)
Septic shock (n=6)
Respiratory failure (n=1)
Drowning (n=1)
Hypothermia (avalanche) (n=1)
Unknown origin (n=1)
Cardiac diagnoses Non-cardiacdiagnoses P value
Survivors Non-survivors Survivors Non-survivors
13 32 1 9 0.22
Outcome
Non-survivorSurvivor
EC
PR
 s
co
re
1 8
1 5
1 4
1 3
1 2
1 1
1 0
9
8
7
6
5
4
3
Page 1
